Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$145.54 - $178.83 $1.67 Million - $2.05 Million
-11,491 Reduced 87.53%
1,637 $283,000
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $196,484 - $237,128
1,186 Added 9.93%
13,128 $2.22 Million
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $640,742 - $846,580
4,231 Added 54.87%
11,942 $2.36 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $194,550 - $224,384
1,164 Added 17.78%
7,711 $1.34 Million
Q2 2023

Aug 07, 2023

BUY
$160.94 - $186.23 $298,060 - $344,897
1,852 Added 39.45%
6,547 $1.13 Million
Q1 2023

May 11, 2023

BUY
$145.48 - $175.02 $683,028 - $821,718
4,695 New
4,695 $781,000
Q3 2022

Nov 10, 2022

BUY
$148.29 - $182.55 $16,905 - $20,810
114 Added 7.55%
1,624 $247,000
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $21,679 - $27,812
139 Added 10.14%
1,510 $260,000
Q1 2022

May 10, 2022

SELL
$181.39 - $234.03 $23,580 - $30,423
-130 Reduced 8.66%
1,371 $263,000
Q4 2021

Feb 07, 2022

SELL
$193.69 - $247.03 $34,283 - $43,724
-177 Reduced 10.55%
1,501 $372,000
Q3 2021

Oct 27, 2021

BUY
$189.29 - $209.69 $317,628 - $351,859
1,678 New
1,678 $326,000
Q2 2021

Aug 10, 2021

SELL
$155.9 - $187.99 $471,909 - $569,045
-3,027 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$144.0 - $169.39 $1.67 Million - $1.97 Million
-11,613 Reduced 79.32%
3,027 $475,000
Q4 2020

Feb 11, 2021

BUY
$157.07 - $174.35 $614,614 - $682,231
3,913 Added 36.48%
14,640 $2.4 Million
Q3 2020

Nov 10, 2020

BUY
$137.1 - $165.37 $52,235 - $63,005
381 Added 3.68%
10,727 $1.64 Million
Q2 2020

Aug 10, 2020

BUY
$111.92 - $142.53 $248,238 - $316,131
2,218 Added 27.29%
10,346 $1.29 Million
Q1 2020

May 20, 2020

BUY
$92.66 - $144.94 $753,140 - $1.18 Million
8,128 New
8,128 $924,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Phoenix Holdings Ltd. Portfolio

Follow Phoenix Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.